Myriad Genetics
MYGN
Myriad Genetics (MYGN) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Hold | $4.50 from $4.00 | Oct 13, 2026 |
| Craig-Hallum | Maintained | Buy | $8.00 from $4.00 | Oct 2, 2026 |
| UBS | Maintained | Neutral | $3.60 from $6.00 | Sep 9, 2026 |
| Piper Sandler | Downgraded | Overweight → Underweight | $2.00 from $5.45 | Sep 1, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $3.00 from $5.00 | Aug 18, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $3.00 from $5.50 | Aug 3, 2026 |
| TD Cowen | Maintained | Hold | $4.00 from $6.00 | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $5.50 from $6.00 | May 6, 2026 |
| TD Cowen | Maintained | Hold | $6.00 from $7.00 | May 6, 2026 |
| UBS | Maintained | Neutral | $6.00 from $8.00 | Feb 24, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $6.00 from $6.50 | Feb 24, 2026 |
| Piper Sandler | Maintained | Overweight | $8.50 from $9.00 | Nov 11, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $6.50 from $6.00 | Nov 5, 2025 |
| UBS | Maintained | Neutral | $8.00 from $6.00 | Nov 4, 2025 |
| TD Cowen | Maintained | Hold | $9.00 from $8.00 | Nov 4, 2025 |
| Scotiabank | Downgraded | Sector Outperform → Sector Perform | $6.00 from $20.00 | May 21, 2025 |
| Piper Sandler | Maintained | Overweight | $9.00 from $12.50 | May 15, 2025 |
| Wells Fargo | Downgraded | Overweight → Equal-Weight | $6.00 from $22.00 | May 8, 2025 |
| Raymond James | Maintained | Outperform | $10.00 from $19.00 | May 7, 2025 |
| UBS | Maintained | Neutral | $7.00 from $16.00 | May 7, 2025 |
Frequently asked questions
What is the latest analyst rating on MYGN?
On Oct 13, 2026, TD Cowen maintained Myriad Genetics at Hold with a price target of $4.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.